DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical ...
AllAfrica on MSN
New African research shapes the future of HIV treatment globally
Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented across ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment ...
AllAfrica on MSN
Twice-yearly lenacapavir injection for HIV prevention in Nigeria - the real test is access
On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results